CritiTech OK’d for $48K in
financing
July 14, 2006
By Mark Fagan - Lawrence Journal World
Kansas State University wasn’t the only college operation
getting good news Thursday from the Kansas Bioscience Authority.
CritiTech, a spinoff company from Kansas University’s
Higuchi Biosciences Center, won approval from the authority’s
board of directors for $48,700 in financing.
The money will be used to buy a new and improved
coating unit, equipment that will help the company test the
feasibility and development of processes and materials for
use by major pharmaceutical companies.
CritiTech, with a lab and offices off Wakarusa
Drive in Lawrence, recently signed contracts with several
pharmaceutical companies. CritiTech is preparing to conduct
human trials of the company’s reformulation of a cancer-fighting
drug, and continues to work on ways to coat medical devices,
such as stents, with medications that can help improve their
performance.
Members of the bioscience authority gathered
Thursday in Overland Park to review and approve projects,
welcome two new members — John Carlin and Ray Smilor
— and elect officers: Clay Blair, chairman; Bill Sanford,
vice chairman; and Sandra Lawrence, secretary-treasurer.
Board members also elected members to serve
on the organization’s executive committee: Blair, Sanford
and Lawrence, along with state Sen. Jim Barone, D-Frontenac,
and Dolph C. Simons Jr., chairman of The World Company, which
owns the Journal-World.
|
